PTC Therapeutics, Inc. (PTCT) FY2026 Q3 Statement of Cash Flows
Published Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)
Statement of Cash Flows
Swipe to see the full flow
Chart details
PTC Therapeutics, Inc. cash flow reconciliation, Jul 1, 2026 through Sep 30, 2026
Cash flows for Jul 1, 2026 through Sep 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Jun 30, 2026. Ending cash: Sep 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Jun 30, 2026
- 1,066,332,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- Operating activities
- negative 25,311,000 US dollars. Net cash used. The remaining amount is calculated by subtracting the other displayed items from the operating total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Tangible asset impairment and losses on transactions, net), so Tangible asset impairment and losses on transactions, net and Loss on extinguishment of debt cannot be separated for this quarter. It may combine inflows and outflows.
- Net (loss) income attributable to common stockholders
- negative 51,693,000 US dollars
- Depreciation and amortization
- 16,817,000 US dollars
- Non-cash operating lease expense
- 1,805,000 US dollars
- Non-cash royalty revenue related to sale of future royalties
- negative 81,684,000 US dollars
- Non-cash interest expense on liability related to sale of future royalties
- 65,853,000 US dollars
- Unrealized gain on marketable securities - equity investments
- negative 1,104,000 US dollars
- Amortization of discounts on investments, net
- negative 5,330,000 US dollars
- Amortization of debt issuance costs
- 770,000 US dollars
- Share-based compensation expense
- 23,827,000 US dollars
- Unrealized foreign currency transaction losses, net
- 179,000 US dollars
- Inventory, net
- negative 18,115,000 US dollars
- Prepaid expenses and other current assets
- negative 4,686,000 US dollars
- Trade and royalty receivables, net
- 42,000 US dollars
- Deposits and other assets
- negative 56,000 US dollars
- Accounts payable and accrued expenses
- 10,692,000 US dollars
- Other liabilities
- negative 2,702,000 US dollars
- Inducement expense related to repurchase of 2026 Convertible Notes
- 0 US dollars
- Deferred revenue
- 811,000 US dollars
- Remaining operating cash flows, net (calculated)
- 19,263,000 US dollars
- Investing activities
- negative 442,412,000 US dollars. Net cash used.
- Purchases of fixed assets
- negative 2,657,000 US dollars
- Purchases of marketable securities- available for sale
- negative 753,250,000 US dollars
- Purchases of marketable securities- equity investments
- negative 5,888,000 US dollars
- Sale of marketable securities- available for sale
- 320,593,000 US dollars
- Sale of marketable securities- equity investments
- 2,156,000 US dollars
- Acquisition of product rights and licenses
- negative 3,366,000 US dollars
- Financing activities
- negative 73,236,000 US dollars. Net cash used. The remaining amount is calculated by subtracting the other displayed items from the financing total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Repurchase of the 2026 Convertible Notes), so Repurchase of the 2026 Convertible Notes and Payments on finance lease principal cannot be separated for this quarter. It may combine inflows and outflows.
- Proceeds from exercise of options
- 5,349,000 US dollars
- Proceeds from employee stock purchase plan
- 0 US dollars
- Proceeds from issuance of 2031 Convertible Notes
- 0 US dollars
- Debt issuance costs related to 2031 Convertible Notes
- negative 822,000 US dollars
- Conversion of the 2026 Convertible Notes
- 0 US dollars
- Remaining financing cash flows, net (calculated)
- negative 77,763,000 US dollars
- Operating adjustment reconciliation
- 165,370,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
- financing displayed reconciliation
- 78,585,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
- investing gross reconciliation
- 765,161,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- negative 38,000 US dollars
- Ending cash on Sep 30, 2026
- 525,335,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- Cash sources and uses
- 1,066,332,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- negative 540,997,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
- Operating cash flow
- negative 25,311,000 US dollars. Operating cash flow used in the free cash flow calculation.
- Cash purchases of property, plant and equipment
- 2,657,000 US dollars. These cash purchases are already included in investing activities above.
- Free cash flow
- negative 27,968,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net loss −$51.69M + net operating adjustments $26.38M = operating cash −$25.31M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 25,311,000 US dollars minus 2,657,000 US dollars equals negative 27,968,000 US dollars.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
